People who suffer with illness usually know the economic impact of something like Fibromyalgia and Chronic Fatigue Syndrome on their lives. Sometimes they can work a little so the illness only affects their bottom line income 50% to 75%, but then there’s the toll on family and friend relationships, hobbies and life aspirations that can be immeasurable.
Other folks may be affected more at the 100% level because they can’t work at all, yet they continue to incur the expenses of living plus trying to get well. They deal with family and friend issues and usually enjoy few outside activities of any kind because they can’t physically, mentally or emotionally tolerate the activity and because they can’t afford them.
Either way you look at the problem, we all can appreciate the exciting announcement about the birth of the …
NeuroEndocrineImmune (NEI) Center, the first research center in the state of New Jersey dedicated to understanding and treating chronic neuroendocrineimmune (NEI) illnesses which includes Chronic Fatigue Syndrome and Fibromyalgia, is currently awaiting passage in the New Jersey State Senate.
NJ state senators cited studies that an estimated 20 million American adults and children suffer with NEI type illnesses: Fibromyalgia, Chronic Fatigue Syndrome, CFS/ME and more.
‘The economic impact and loss of worker productivity in the United States due to CFS/ME, alone, is estimated to be over $9 billion per year. Chronic illness represents 75% of all the health care costs in the U.S.’
According to Senator Loretta Weinberg (D): “It makes sense to locate the NEI center in New Jersey. As the nation’s medicine chest, New Jersey is home to research institutions and private businesses that can cooperate to find a cure for these debilitating diseases.”
Let’s hope this is one bill that passes. The NeuroEndocrineImmuneCenter could be very important. Spend a little. Save a lot. *Remember: we’re a drain on the national pocketbook unless they come up with an answer!
Thanks, Cinda Crawford, host of the Health Matters Show
{ 2 trackbacks }
{ 0 comments… add one now }